The Board of Directors of Liaoning Chengda Biotechnology Co.,Ltd. has authorized a buyback plan on March 11, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.99 CNY | +0.15% | -4.76% | -20.06% |
20/05 | Wall Street Cues, Central Bank Outlooks Lift Asian Stock Markets | MT |
29/04 | Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.06% | 1.48B | |
+0.82% | 91.94B | |
-1.32% | 38.74B | |
+64.07% | 26.66B | |
-16.31% | 15.32B | |
-5.78% | 13.3B | |
-11.38% | 11.65B | |
+173.10% | 10.37B | |
-49.84% | 10.12B | |
+4.19% | 9.06B |
- Stock Market
- Equities
- 688739 Stock
- News Liaoning Chengda Biotechnology Co.,Ltd.
- Liaoning Chengda Biotechnology Co.,Ltd. authorizes a Buyback Plan.